clinical trial · NCT06260514
Study of APR-1051 in Patients With Advanced Solid Tumors
Advanced Solid TumorAPR-1051
brief summary
The purpose of this study is to assess the safety and effectiveness of APR-1051 through the performance of a Phase 1, open-label, safety, PK, and preliminary efficacy study of oral APR-1051 in patients with advanced solid tumors.
started
Jun 13, 2024
primary completion
Jun 1, 2027
completion
Jun 1, 2028
last updated
Apr 23, 2026
official title
A Phase 1, Open-Label, Multicenter, First-In-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of APR-1051 in Patients With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol